Trulicity - supply shortage

Resolved

dulaglutide

Shortage information

The shortage affecting Trulicity has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Trulicity
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  dulaglutide
• Therapeutic area (MESH):
  Diabetes Mellitus, Type 2
• Pharmaceutical forms affected:
  Solution for injection in pre-filled pen
• Strengths affected:
  • 0.75 mg
  • 1.5 mg
  • 3 mg
  • 4.5 mg
• Availability of alternatives:
  Yes

Key dates

• Expected resolution:
  End of 2025
• First published:
  28/08/2023
• Last updated:
  17/02/2026